BRPI0514430A - composto de rutênio (ii) ou um solvato ou pró-droga do mesmo, composição, uso de um composto, e, método de tratamento de um indivìduo que sofre de cáncer - Google Patents
composto de rutênio (ii) ou um solvato ou pró-droga do mesmo, composição, uso de um composto, e, método de tratamento de um indivìduo que sofre de cáncerInfo
- Publication number
- BRPI0514430A BRPI0514430A BRPI0514430-2A BRPI0514430A BRPI0514430A BR PI0514430 A BRPI0514430 A BR PI0514430A BR PI0514430 A BRPI0514430 A BR PI0514430A BR PI0514430 A BRPI0514430 A BR PI0514430A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- solvate
- donor
- cancer
- carbocyclic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000012453 solvate Substances 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- 150000003304 ruthenium compounds Chemical class 0.000 title 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 5
- 125000002837 carbocyclic group Chemical group 0.000 abstract 3
- 239000003446 ligand Substances 0.000 abstract 2
- 125000003627 8 membered carbocyclic group Chemical group 0.000 abstract 1
- MSOONVMMTIVQIJ-UHFFFAOYSA-N S(=O)(=O)(O)S(=O)(=O)NONS(=O)(=O)S(=O)(=O)O Chemical compound S(=O)(=O)(O)S(=O)(=O)NONS(=O)(=O)S(=O)(=O)O MSOONVMMTIVQIJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- -1 ruthenium (II) compound Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 150000003568 thioethers Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0418643.3A GB0418643D0 (en) | 2004-08-20 | 2004-08-20 | Ruthenium (II) compounds |
| PCT/GB2005/003242 WO2006018649A1 (en) | 2004-08-20 | 2005-08-19 | Arene ruthenium (ii) compounds and their use in cancer therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0514430A true BRPI0514430A (pt) | 2008-05-06 |
Family
ID=33042406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0514430-2A BRPI0514430A (pt) | 2004-08-20 | 2005-08-19 | composto de rutênio (ii) ou um solvato ou pró-droga do mesmo, composição, uso de um composto, e, método de tratamento de um indivìduo que sofre de cáncer |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1786412A1 (no) |
| JP (1) | JP2008510693A (no) |
| KR (1) | KR20070060091A (no) |
| CN (1) | CN101043885A (no) |
| AU (1) | AU2005273726A1 (no) |
| BR (1) | BRPI0514430A (no) |
| CA (1) | CA2578280A1 (no) |
| GB (1) | GB0418643D0 (no) |
| MX (1) | MX2007002099A (no) |
| NO (1) | NO20071481L (no) |
| WO (1) | WO2006018649A1 (no) |
| ZA (1) | ZA200702093B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006017594A1 (de) * | 2006-04-13 | 2007-10-18 | Wacker Chemie Ag | Neuartige Ru-Komplexe, deren Herstellung und Verwendung |
| WO2007128158A1 (en) | 2006-05-09 | 2007-11-15 | Ecole Polytechnique Federale De Lausanne (Epfl) | Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis |
| GB0711849D0 (en) * | 2007-06-19 | 2007-07-25 | Oxford Biosensors Ltd | Redox Mediators |
| EP2067771A1 (en) | 2007-12-03 | 2009-06-10 | EPFL Ecole Polytechnique Fédérale de Lausanne | Derivatives of Dihydroxypyrrolidine as Anti-Cancer Compounds |
| EP2409697A1 (en) | 2010-07-20 | 2012-01-25 | Université de Neuchâtel | Medicaments Based on Dinuclear Ruthenium, Osmium and Iron Complexes Comprising Triply Bridging Thiolato, Selenolato, Alkoxo and/or Amido Ligands |
| WO2013038395A1 (en) | 2011-09-16 | 2013-03-21 | Universidade De Lisboa | Transition metal complexes for pharmaceutical applications |
| WO2013136296A2 (en) | 2012-03-14 | 2013-09-19 | Universidade De Lisboa | Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands |
| CN105377862B (zh) | 2013-03-15 | 2019-09-13 | 希瑞·安·麦克法兰 | 用作光动力化合物的金属基配合物及其用途 |
| US9751081B2 (en) | 2014-12-01 | 2017-09-05 | Clemson University | Self-regenerating antioxidant catalysts and methods of using the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19736152A1 (de) * | 1997-08-14 | 1999-02-18 | Martin Wehlan | Azido-Aziridinkomplexe, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DK1224192T3 (da) * | 1999-10-27 | 2006-01-02 | Univ Court The University Of E | Halvsandwich-ruthenium (II)-forbindelser omfattende nitrogenholdige ligander til behandling af cancer |
| GB0016052D0 (en) * | 2000-06-30 | 2000-08-23 | Univ Edinburgh | Ruthenium (II) compounds |
| GB0215526D0 (en) * | 2002-07-05 | 2002-08-14 | Univ Edinburgh | Anticancer compounds |
-
2004
- 2004-08-20 GB GBGB0418643.3A patent/GB0418643D0/en not_active Ceased
-
2005
- 2005-08-19 CA CA002578280A patent/CA2578280A1/en not_active Abandoned
- 2005-08-19 KR KR1020077006364A patent/KR20070060091A/ko not_active Application Discontinuation
- 2005-08-19 MX MX2007002099A patent/MX2007002099A/es not_active Application Discontinuation
- 2005-08-19 EP EP05771813A patent/EP1786412A1/en not_active Withdrawn
- 2005-08-19 AU AU2005273726A patent/AU2005273726A1/en not_active Abandoned
- 2005-08-19 CN CNA2005800355417A patent/CN101043885A/zh active Pending
- 2005-08-19 WO PCT/GB2005/003242 patent/WO2006018649A1/en active Application Filing
- 2005-08-19 BR BRPI0514430-2A patent/BRPI0514430A/pt not_active IP Right Cessation
- 2005-08-19 JP JP2007526570A patent/JP2008510693A/ja active Pending
-
2007
- 2007-03-12 ZA ZA200702093A patent/ZA200702093B/xx unknown
- 2007-03-20 NO NO20071481A patent/NO20071481L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB0418643D0 (en) | 2004-09-22 |
| KR20070060091A (ko) | 2007-06-12 |
| EP1786412A1 (en) | 2007-05-23 |
| MX2007002099A (es) | 2007-04-24 |
| AU2005273726A1 (en) | 2006-02-23 |
| JP2008510693A (ja) | 2008-04-10 |
| CA2578280A1 (en) | 2006-02-23 |
| NO20071481L (no) | 2007-05-16 |
| WO2006018649A1 (en) | 2006-02-23 |
| ZA200702093B (en) | 2008-08-27 |
| CN101043885A (zh) | 2007-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0514430A (pt) | composto de rutênio (ii) ou um solvato ou pró-droga do mesmo, composição, uso de um composto, e, método de tratamento de um indivìduo que sofre de cáncer | |
| BR0111667A (pt) | Novos compostos | |
| PT1263725E (pt) | Novos compostos | |
| BR0312560A (pt) | Novas espiropiperidinas ou espiropirrolidinas tricìclicas | |
| TR200003256T2 (tr) | P-38 mapkinaz engelleyicileri olan pirazol türevleri | |
| DK0749432T3 (da) | 9-deoxotaxan-forbindelser | |
| BR0014133A (pt) | Uso de um composto, composto, métodos de preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica | |
| BRPI0416004A (pt) | composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método para o tratamento de doenças mediadas por glk, uso de um composto ou um sal, solvato ou pró-droga do mesmo, métodos para o tratamento combinado de obesidade e diabetes e para o tratamento de obesidade, e, processo para a preparação de um composto ou um sal, pró-droga ou solvato do mesmo | |
| SE9904505D0 (sv) | Novel compounds | |
| MXPA05010652A (es) | Pirazoles sustituidos. | |
| MXPA05008690A (es) | Derivados de adamantano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| SE9901875D0 (sv) | Novel compounds | |
| ATE365740T1 (de) | Substituierte pyrazolopyrimidine | |
| SE0302192D0 (sv) | Novel compounds | |
| AR029403A1 (es) | Derivados n-sustituidos de carbamoiloxialquil-azolio,un proceso para su fabricacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento | |
| BR9809598A (pt) | Uso de compostos, e, composto. | |
| SE0302139D0 (sv) | Novel compounds | |
| TW200604197A (en) | New compounds | |
| JP2008510693A5 (no) | ||
| DE60301339D1 (de) | Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen | |
| ATE273281T1 (de) | Heterozyklische cytotoxische wirkstoffe | |
| BR0308071A (pt) | Inibidores da protéina farnesil transferase como agentes antitumores | |
| BRPI0413384A (pt) | inibidores da proteìna farnesil transferase como agentes antitumores | |
| SE0401763D0 (sv) | Compounds | |
| DE60001850T2 (de) | Chalcon coumarine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |